Bristol-Myers Squibb Co.

A $150 million settlement has been approved in the class action lawsuit filed on behalf of investors who bought the company's common stock in 2000 and 2001. The suit alleged that the company had improperly booked $1.5 billion in revenue in 2000 and 2001 by coaxing wholesalers to buy more of its drugs than they could sell. (Sep-02-04)

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no obligation, please fill in our form on the right to submit your complaint.

Add Your Comment on This Issue

Please read our comment guidelines before posting.

Note: Your name will be published with your comment.

Your email will only be used if a response is needed.

Request Legal Help